Antibiotics and Vaccines — Current Affairs 2026
Current Affairs Connections
India's National Action Plan on AMR (NAP-AMR) 2.0 Focuses on One Health Integration
October 2023The Ministry of Health and Family Welfare (MoHFW), in collaboration with other ministries, has been actively updating and implementing the National Action Plan on Antimicrobial Resistance (NAP-AMR). The latest iterations and discussions in 2023-2024 emphasize a stronger 'One Health' approach, integrating human, animal, and environmental health sectors to combat AMR more effectively. This includes enhanced surveillance, improved infection prevention and control in healthcare and animal husbandry settings, and promoting rational use of antibiotics across all sectors. This holistic strategy is critical for UPSC aspirants to understand the multi-faceted nature of AMR and India's policy response (MoHFW 2023 report).
UPSC Angle: Policy initiatives, One Health concept, inter-ministerial coordination, public health challenges, and India's global commitments to AMR. Mains GS-II (Health Policy) and GS-III (Science & Technology, Environment).
Gennova Biopharmaceuticals' mRNA Vaccine, GEMCOVAC-OM, Receives EUA for Omicron Variant
January 2023Gennova Biopharmaceuticals' mRNA vaccine, GEMCOVAC-OM, became India's first indigenously developed mRNA vaccine specifically targeting the Omicron variant of SARS-CoV-2 to receive Emergency Use Authorization (EUA) from the DCGI. This development signifies India's growing capabilities in advanced vaccine technology, moving beyond traditional platforms. It highlights the rapid adaptability of mRNA technology to new variants and strengthens India's pandemic preparedness infrastructure, showcasing the potential of pharmaceutical biotechnology UPSC preparation (DCGI 2023 notification).
UPSC Angle: Vaccine technology (mRNA platforms), indigenous R&D, pandemic preparedness, regulatory approval processes (EUA, DCGI), and India's role in global health innovation. Mains GS-III (Science & Technology) and Prelims (Current Events).
Government Expands Jan Aushadhi Kendras to Boost Access to Affordable Medicines
March 2024The Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP) continues its expansion, with the government announcing plans to significantly increase the number of Jan Aushadhi Kendras across the country. This initiative aims to make quality generic medicines, including essential antibiotics, accessible and affordable to all, particularly in rural and underserved areas. This policy directly addresses issues of equitable access and affordability of healthcare, which are critical components of the Right to Health under Article 21 (Department of Pharmaceuticals 2024 press release).
UPSC Angle: Government schemes for public welfare, healthcare access, affordability of medicines, pharmaceutical policy, and socio-economic development. Mains GS-II (Government Policies & Interventions) and Prelims (Schemes).